awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37669457-24459FBB-7F5C-43D6-9495-942B3F4175F6
Q37669457-24459FBB-7F5C-43D6-9495-942B3F4175F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37669457-24459FBB-7F5C-43D6-9495-942B3F4175F6
Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) study.
P2860
Q37669457-24459FBB-7F5C-43D6-9495-942B3F4175F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37669457-24459FBB-7F5C-43D6-9495-942B3F4175F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c18618bb333ce919d3c27e3a4d5c0a0c3523ac69
P2860
CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study.